Search
for
Sort by
Research 361–390 of 1000+
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- New and Emerging Therapies for Alopecia Areata
- Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: A case report and review of the literature
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Cure of alopecia areata after eradication of Helicobacter pylori: a new association?
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Phototherapy for alopecia areata
- Evaluation of utility of phenol in alopecia areata
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Alopecia areata following COVID-19 vaccine: a systematic review
- Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata
- Alopecia areata
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study